Brain response to a diabetes drug in healthy weight and obesity
Part of Hormones & metabolism clinical trials.
This study looks at how a medication that mimics a natural gut hormone affects brain activity related to appetite in people with healthy weight or obesity. It may help researchers find new ways to treat obesity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You either have a healthy weight (BMI 18.5–25) with normal blood sugar, or you have obesity (BMI 30 or higher) with slightly elevated blood sugar.
- You are not currently taking any medications for diabetes, weight loss, or appetite control.
- You have no serious medical conditions (heart disease, kidney or liver problems) and no history of eating disorders.
- You are not pregnant, breastfeeding, or using hormonal birth control (if you are a woman).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a GLP-1 receptor agonist (a type of diabetes medicine) changes how the brain responds to insulin in people with different body sizes. It may help understand if this drug can improve brain function related to insulin.
This study tests an experimental drug (NNC0487-0111) to see how it changes food intake, appetite, and the way your body processes food after meals. It is for adults with obesity who do not have diabetes.
This study tests a new oral medication called ACCG-2671 to see how safe it is and how your body handles it. It's an early-stage trial, so the main focus is on safety and tolerability. The study has different parts: one for people with normal weight and one for people with higher weight who are already taking a GLP-1 injection for weight loss.
This study looks at how gut hormones and blood sugar control change after Roux-en-Y gastric bypass. It may help researchers understand what supports healthier glucose levels after bariatric surgery.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This study tests an experimental drug called IBI3042 in healthy people who are normal weight, overweight, or obese. It is an early-stage trial looking at how safe and tolerable the drug is, and how it affects the body, which could eventually lead to a treatment for weight loss.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.